THALES
Enterprises can now reduce cyber risk and secure their digital transformation initiatives in new markets including Blockchain, Cloud, DevOps, IoT and Code Signing as Thales unveils an expansion of its data protection ecosystem to more than 300 technology partners.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200812005038/en/
Through these expanded technology integrations, which now include more than 500 IT products and services, Thales is enabling more organisations to integrate its data encryption, hardware security modules, key management and access management technologies with their existing IT infrastructure and cloud services to protect applications, data and identities. This will empower organisations to implement centralised data protection and access management controls for the whole customer journey.
“The use of the cloud and digital transformation is now the cornerstone of any modern company,” said Sebastien Cano, Senior Vice President for Cloud Protection and Licensing Activities at Thales . “Vitally though, those that are truly leading the way are doing so by integrating security by design into their processes from the start. By integrating our data protection products and services with hundreds of technology partners, we can ensure customers and their sensitive data are protected throughout their entire transformation journey and remain at the forefront of their industries.”
Protecting Blockchain
Thales is collaborating with leading companies that are driving the adoption of Blockchain technology by integrating its Luna Network Hardware Security Modules (HSM) as the root of trust to secure blockchain-based transactions. Recently, Thales integrated its Luna Network HSM with CLS Group – a dedicated crypto processor that is specifically designed for the protection of the crypto key lifecycle – and Hyperledger – a multi-project open source collaborative effort hosted by The Linux Foundation, created to advance cross-industry blockchain technologies.
Enabling Secure Cloud Transformation
Today, organisations on average use 29 cloud services for their collaboration, computing, customer relationship management and storage needs. Thales is helping companies secure the move to the cloud with cloud key management and access management solutions that integrate with the most widely used cloud platforms and services including AWS, Azure, Box, Office365 and Slack.
Thales’s SafeNet Trusted Access enables organisations to modernise their IT and Identity and Access Management (IAM) schemes, as part of their cloud transformation initiatives. For example, integrations with IGA vendors such as SailPoint enable secure identity governance and identity management workflows; Security for privileged users is achieved by securing PAM solutions such as BeyondTrust, at the access point; and continuous authentication and access control is enabled by working with CipherCloud’s CASB solution.
Securing Hybrid IT Environments
While organisations are rapidly adopting cloud services and moving infrastructure to the cloud, the majority are maintaining hybrid IT environments. One of the key challenges they face in doing so is bridging between modern and cloud IAM schemes. To this end, SafeNet Trusted Access’s integration with F5 BIG IP enables enterprises to implement smart SSO for cloud services while securing on premises legacy applications.
“Data and applications are fast becoming the lifeblood of any organisation, no matter the industry,” said John Morgan, VP & GM Security at F5 . “For any customer to truly take advantage of this digital transformation, applications and their underlying data must be secure. By joining the Thales partner ecosystem, we are continuing our long history of collaboration to help customers achieve positive business outcomes through secure digital transformation.”
Enabling Trust for DevOps
Digital certificates play an integral role in DevOps workflows, securing authentication across users, devices and applications. The secure identities and certificates establish trust within enterprise infrastructure, pipeline, code and containers. Thales has expanded its DevOps technology partners to include Red Hat, HashiCorp, Kubernetes, VMWare Tanzu, Docker and Google for secure DevOps to enable customers to realise the benefits of automation, scale, & cloud native applications and digital transformation.
Securing the Identities and Data in IoT
In order to secure, manage and authenticate the billions of identities that will be created with the Internet of Things, Thales has recently expanded integrations for its HSMs, Data Encryption and Key Management solutions with leading providers of IoT security solutions such as Cisco, Microsoft, DigiCert, Sectigo, GlobalSign, KeyFactor and Venafi to help organisations secure the billions of identities that will be created over the next few years.
Code Signing becomes an essential service for businesses
Code signing has emerged as an essential ingredient to doing business for virtually any organisation that distributes code to customers and partners. Code signing verifies who the publisher of a specific set of code is and attests that it has not been modified since it was signed. Certificates delivered along with software that has been signed are a key way for users to determine whether software originates from a legitimate source before installing. Today, many software marketplaces, including mobile app stores, require code to be compliant with specific digital signing requirements.
One of those mandates is for applicants to generate and store their private key using a FIPS 140-2 Level 2 certified hardware solution. This can be a Hardware Security Module (HSM) that protects the identity, whether it is the server, virtualization server or the user. Thales' HSMs take the security one step further by storing the signing material in a hardware device, thus ensuring authenticity and integrity of a code file. Thales code signing partners include Adobe, DigiCert, Garantir GlobalSign, Keyfactor, Microsoft and Venafi.
About Thales Thales (Euronext Paris: HO) is a global technology leader shaping the world of tomorrow today. The Group provides solutions, services and products to customers in the aeronautics, space, transport, digital identity and security, and defence markets. With 83,000 employees in 68 countries, Thales generated sales of €19 billion in 2019 (on a pro forma basis including Gemalto over 12 months). Thales is investing in particular in digital innovations — connectivity, Big Data, artificial intelligence and cybersecurity — technologies that support businesses, organisations and governments in their decisive moments. |
PLEASE VISIT
Thales Group
Market page
View source version on businesswire.com: https://www.businesswire.com/news/home/20200812005038/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release
Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem
Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 11:08:00 CET | Press release
Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played
Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 10:44:00 CET | Press release
At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will
Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 10:00:00 CET | Press release
Anthropic’s safety-first AI meets Allianz's dedication to customer centricity, stakeholder trust, and regulatory excellenceThree focus areas of the partnership: workforce empowerment, operations automation through agentic AI, and regulatory compliance Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE.
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 07:00:00 CET | Press release
MH002 is currently the most advanced Live Biotherapeutic Product (LBP) based on a rationally-designed combination of disease specific bacteria (microbial consortia), for the treatment of inflammatory bowel diseases (IBD) STARFISH-UC Phase 2b trial is designed to confirm MH002’s early efficacy signals and favorable safety observed in Phase 2a studies MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
